01355nam a2200325Ia 4500001001200000003000800012005001700020006001900037007001500056008004100071020001500112040002100127035002100148050002500169090001700194245017600211260002800387300001000415500003300425533015200458610007800610650002800688650004700716655003400763700002100797710002200818730004100840856013100881999001701012ebr10047370CaPaEBR20260707173944.0m        u        cr cn|||||||||040210s2003    sz     gs     000 0 eng d  z380557665X  aCaPaEBRcCaPaEBR  a(OCoLC)64728825714aR853.C55bS73 2003eb  c62900d6042400aStandard operating procedure for clinical trials of the CESAR Central European Society for Anticancer Drug Research - EWIVh[electronic resource] /cG. Gastl ... [et al.].  aBasel :bKarger,c2003.  a74 p.  aAt head of title: Onkologie.  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2009.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries.20aCESAR Central European Society for Anticancer Drug ResearchxEWIV.995245 0aClinical trials.995246 0aAntineoplastic agentsxDevelopment.995247 7aElectronic books.2local91901 aGastl, G.9952482 aebrary, Inc.91910 aOnkologie.nBd. 26, suppl. 6.99524940uhttp://site.ebrary.com/lib/strathmore/Doc?id=10047370zAn electronic book accessible through the World Wide Web; click to view  c62900d60424